Edwards Lifesciences Corporation (EW) NYSE

83.84

+0.83(+1.00%)

Updated at January 13 04:00PM

Currency In USD

Valuation

Market Cap44.25B
Enterprise Value41.9B
P/E Ratio35.93
PEG Ratio-0.54
Price/Sales Ratio8.37
Price/Book Ratio4.8
Enterprise/Revenue8.03
Enterprise/EBITDA27.12

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.23
Operating Margin0.27

Management Effectiveness

Return On Assets0.1
Return On Equity0.13

Income Statement

Revenue5.44B
Revenue/Share10.06
Gross Profit4.32B
EBITDA1.72B
Net Income4.17B
Diluted EPS6.97

Balance Sheet

Total Cash3.84B
Total Cash/Share6.57
Total Debt700.3M
Total Debt/Equity0.07
Current Ratio4
Book Value Per Share17.45

Price History

52-Week Change18.02
52-Week High87.89
52-Week Low65.94
Moving Average 50 Days84.88
Moving Average 200 Days78.42

Statistics

Average Volume3.94M
Shares Outstanding587.15M
% Held by Institutions83.59

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor3:1
Last Split DateJune 01, 2020